It’s hard to believe PD-MitoQUANT has been on the go for six months!

Learn more about the team and the project in our first newsletter

Join the conversation on social media at #PDMitoQUANT



This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.